GURUFOCUS.COM » STOCK LIST » Basic Materials » Forest Products » China Health Technology Group Holding Co Ltd (HKSE:01069) » Definitions » PS Ratio

China Health Technology Group Holding Co (HKSE:01069) PS Ratio : 0.11 (As of May. 29, 2024)


View and export this data going back to 2009. Start your Free Trial

What is China Health Technology Group Holding Co PS Ratio?

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, China Health Technology Group Holding Co's share price is HK$0.078. China Health Technology Group Holding Co's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was HK$0.69. Hence, China Health Technology Group Holding Co's PS Ratio for today is 0.11.

The historical rank and industry rank for China Health Technology Group Holding Co's PS Ratio or its related term are showing as below:

HKSE:01069' s PS Ratio Range Over the Past 10 Years
Min: 0.08   Med: 13.89   Max: 98.65
Current: 0.11

During the past 13 years, China Health Technology Group Holding Co's highest PS Ratio was 98.65. The lowest was 0.08. And the median was 13.89.

HKSE:01069's PS Ratio is ranked better than
94.44% of 288 companies
in the Forest Products industry
Industry Median: 0.72 vs HKSE:01069: 0.11

China Health Technology Group Holding Co's Revenue per Sharefor the six months ended in Dec. 2023 was HK$0.33. Its Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was HK$0.69.

Warning Sign:

China Health Technology Group Holding Co Ltd revenue per share has been in decline for the last 5 years.

During the past 12 months, the average Revenue per Share Growth Rate of China Health Technology Group Holding Co was -70.60% per year. During the past 3 years, the average Revenue per Share Growth Rate was 6.40% per year. During the past 5 years, the average Revenue per Share Growth Rate was -36.90% per year. During the past 10 years, the average Revenue per Share Growth Rate was -24.00% per year.

During the past 13 years, China Health Technology Group Holding Co's highest 3-Year average Revenue per Share Growth Rate was 29.10% per year. The lowest was -68.80% per year. And the median was -13.50% per year.

Back to Basics: PS Ratio


China Health Technology Group Holding Co PS Ratio Historical Data

The historical data trend for China Health Technology Group Holding Co's PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China Health Technology Group Holding Co PS Ratio Chart

China Health Technology Group Holding Co Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Jun22 Jun23
PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.78 2.48 13.89 13.89 1.72

China Health Technology Group Holding Co Semi-Annual Data
Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Dec21 Jun22 Dec22 Jun23 Dec23
PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 13.89 - 1.72 -

Competitive Comparison of China Health Technology Group Holding Co's PS Ratio

For the Lumber & Wood Production subindustry, China Health Technology Group Holding Co's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


China Health Technology Group Holding Co's PS Ratio Distribution in the Forest Products Industry

For the Forest Products industry and Basic Materials sector, China Health Technology Group Holding Co's PS Ratio distribution charts can be found below:

* The bar in red indicates where China Health Technology Group Holding Co's PS Ratio falls into.



China Health Technology Group Holding Co PS Ratio Calculation

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.

China Health Technology Group Holding Co's PS Ratio for today is calculated as

PS Ratio=Share Price/Revenue per Share (TTM)
=0.078/0.686
=0.11

China Health Technology Group Holding Co's Share Price of today is HK$0.078.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. China Health Technology Group Holding Co's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was HK$0.69.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

PS Ratio=Market Cap/Revenue

The Revenue here is for the trailing 12 months.


China Health Technology Group Holding Co  (HKSE:01069) PS Ratio Explanation

The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.

When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.

Similar to the PE Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PS Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.


China Health Technology Group Holding Co PS Ratio Related Terms

Thank you for viewing the detailed overview of China Health Technology Group Holding Co's PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


China Health Technology Group Holding Co (HKSE:01069) Business Description

Traded in Other Exchanges
Address
Binhe Road South, Room 4101, Phase II Jingji Binhe Shidai Tower North, Futian District, Shenzhen, CHN
China Health Technology Group Holding Co Ltd Formerly China Bozza Development Holdings Ltd is an investment holding company. It is engaged in the business of management of new agriculture and forestry resources in the People's Republic of China. The company has two reportable segments including the Forestry business and Ginseng Business. The forestry management business includes plantation, logging, and sale of timber-related products and the Ginseng Business includes ginseng plantation and trading of related products. The company generates a majority of its revenue from the Ginseng business segment. Geographically company generates its key revenue from the PRC.
Executives
Huang Hou 2201 Interest of corporation controlled by you
Huang Hou 2101 Beneficial owner
Able Planet International Limited
China Bozza Scheme Limited
Arab Osman Mohammed
Lai Wing Lun
Wang Yue 2101 Beneficial owner
Long Yijia 2202 Interest of your spouse

China Health Technology Group Holding Co (HKSE:01069) Headlines

No Headlines